2.
Continued | ||||||
Characteristics | Univariate analysis | Multivariate analysis | ||||
Mean survival (month) (95% CI) | Log rank | P | HR (95% CI) | P | ||
*P < 0.05 was considered statistically significant. Abbreviations: ER, estrogen receptor; Her-2, human epidermal growth factor receptor 2; HR(+), hormonal receptor (+); PR, progestrone receptor; TN, triple negative. | ||||||
> 25% | 44 (35–53) | 1.093 (0.449–2.664) | 0.844 | |||
Ki67 decrease | 7.327 | 0.007* | ||||
≤ 12.5% | 46 (37–54) | 1 | ||||
> 12.5% | 66 (59–74) | 0.353 (0.147–0.850) | 0.020* | |||
Molecular subtype | 5.875 | 0.118 | ||||
HR(+)/Her-2(–) | 62 (54–70) | |||||
HR(+)/Her-2(+) | 62 (46–77) | |||||
HR(–)/Her-2(+) | 43 (29–56) | |||||
TN | 41 (23–58) |